Lee’s Pharmaceutical Mergers & Acquisitions

Lee’s Pharmaceutical M&A Summary

Lee’s Pharmaceutical has acquired 1 company, including 1 in the last 5 years.

Lee’s Pharmaceutical has acquired in 1 US state. The Company’s most targeted sectors include life science (100%).

M&A Summary

  • M&A Total Activity1
    • M&A Buy Activity1
  • Total Sectors Invested 1
  • Total Countries Invested 1
  • M&A Buy/Sell Connections 1

Lee’s Pharmaceutical

Lee's Pharmaceutical Holdings Ltd.

1/F, Building 20E, Phase 3, Hong Kong Science Park, Shatin,
Hong Kong,
China,
+852 2314 1282
www.leespharm.com

All (1) Buy (1) Sell (-)
Date Target Value
$mlns
Transaction Type Acquirer Seller SRC
Link
2025-12-09 Staccato OBT · Life Science
Mountain View, California · www.staccatoobt.com

Staccato OBT is a breath-activated drug-delivery platform originally developed to deliver aerosolized medicines rapidly, non-invasively, with onset times similar to intravenous administration. The technology has been applied to therapeutic programs such as loxapine for acute agitation and is being developed for other central-nervous-system indications in collaboration with biopharmaceutical partners.

- Divestiture

Lee’s Pharmaceutical

Alexza Pharmaceuticals, Inc.


Try Mergr Free — See This and 221,260+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 215K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.